Research Article
Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma
Table 2
Univariate Cox regression analysis of overall survival and cancer-specific survival in nasopharyngeal carcinoma in the training cohort.
| Variables | Overall survival | Cancer-specific survival | HR | 95% CI | | HR | 95% CI | |
| Total | | | | | | | Age group (years) | | | | | | | <50 | Reference | | | Reference | | | 50-64 | 1.854 | 1.628-2.112 | <0.001 | 1.639 | 1.420-1.891 | <0.001 | ≥65 | 3.419 | 2.989-3.912 | <0.001 | 2.490 | 2.136-2.903 | <0.001 | Sex | | | | | | | Male | Reference | | | Reference | | | Female | 0.884 | 0.791-0.9883 | 0.03 | 0.882 | 0.775-1.002 | 0.054 | Race | | | | | | | Black | Reference | | | Reference | | | White | 1.031 | 0.886-1.201 | 0.693 | 0.924 | 0.777-1.099 | 0.372 | Asian/Pacific islander | 0.601 | 0.509-0.707 | <0.001 | 0.631 | 0.525-0.759 | <0.001 | Indian/Alaska native | 1.455 | 1.017-2.083 | 0.040 | 1.412 | 0.939-2.122 | 0.097 | Marital status | | | | | | | Single | Reference | | | Reference | | | Married | 0.971 | 0.855-1.104 | 0.655 | 0.925 | 0.801-1.069 | 0.292 | Divorced | 1.624 | 1.357-1.945 | <0.001 | 1.493 | 1.213-1.837 | <0.001 | Windowed/separated | 2.486 | 2.058-3.004 | <0.001 | 2.113 | 1.693-2.636 | <0.001 | Histology | | | | | | | KSCC | Reference | | | Reference | | | DNKC | 0.599 | 0.523-0.686 | <0.001 | 0.619 | 1.616-0.722 | <0.001 | UNKC | 0.446 | 0.379-0.522 | <0.001 | 0.429 | 2.328-0.518 | <0.001 | Others | 0.724 | 0.639-0.820 | <0.001 | 0.707 | 1.414-0.817 | <0.001 | Grade | | | | | | | Well | Reference | | | Reference | | | Moderate | 1.106 | 0.774-1.580 | 0.581 | 1.135 | 0.747-1.726 | 0.553 | Poor | 0.744 | 0.531-1.043 | 0.086 | 0.795 | 0.535-1.182 | 0.258 | Undifferentiated | 0.463 | 0.329-0.653 | <0.001 | 0.478 | 0.319-0.715 | <0.001 | Unknown | 0.667 | 0.475-0.936 | 0.019 | 0.699 | 0.469-1.042 | 0.079 | Tumor size (cm) | | | | | | | <3 | Reference | | | Reference | | | 3-5 | 1.348 | 1.147-1.585 | <0.001 | 1.377 | 1.137-1.667 | <0.001 | >5 | 2.089 | 1.738-2.510 | <0.001 | 2.387 | 1.933-2.946 | <0.001 | Unknown | 1.521 | 1.308-1.768 | <0.001 | 1.634 | 1.368-1.953 | <0.001 | AJCC stage | | | | | | | I | Reference | | | Reference | | | II | 1.038 | 0.827-1.303 | 0.748 | 1.259 | 0.924-1.716 | 0.144 | III | 1.289 | 1.036-1.603 | 0.023 | 1.857 | 1.383-2.494 | <0.001 | IV | 2.268 | 1.838-2.799 | <0.001 | 3.551 | 2.668-4.726 | <0.001 | T stage | | | | | | | T1 | Reference | | | Reference | | | T2 | 1.117 | 0.968-1.288 | 0.129 | 1.217 | 1.028-1.441 | 0.023 | T3 | 1.555 | 1.351-1.792 | <0.001 | 1.716 | 1.453-2.027 | <0.001 | T4 | 1.974 | 1.726-2.258 | <0.001 | 2.303 | 1.970-2.692 | <0.001 | N stage | | | | | | | N0 | Reference | | | Reference | | | N1 | 0.76 | 0.666-0.867 | <0.001 | 0.803 | 0.686-0.939 | 0.006 | N2 | 0.876 | 0.767-0.999 | 0.049 | 0.997 | 0.855-1.163 | 0.970 | N3 | 1.284 | 1.093-1.509 | 0.002 | 1.536 | 1.280-1.844 | <0.001 | M stage | | | | | | | M0 | Reference | | | Reference | | | M1 | 3.182 | 2.756-3.676 | <0.001 | 3.905 | 3.353-4.549 | <0.001 | Chemotherapy | | | | | | | Yes | Reference | | | Reference | | | No/unknown | 1.312 | 1.144-1.505 | <0.001 | 1.207 | 1.026-1.421 | <0.001 |
|
|